Trials / Completed
CompletedNCT04785313
Anatomopathological Analysis and Clinical Evolution After Radiological Removal of Retrievable Vena Cava Filters
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 85 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pulmonary embolism (PE) is a common pathology causing significant morbidity and mortality. It is usually secondary to migration through the inferior vena cava (IVC) of a formed thrombus in the veins of the lower limbs or pelvis. The inferior vena cava filter (IVCF) is a medical device whose purpose is to prevent thrombus migration from the veins of the legs and pelvis to the pulmonary arteries, thus preventing the occurrence of Pulmonary embolism (PE). There is no data on the interactions of Retrievable inferior vena cava filters (IVCF) with the inferior vena cava (intrafilter thrombi, insertion through the venous wall) although it may modify the evolution after IVCF retrievable.
Detailed description
The main objective of this study is to determine whether the presence of intrafilter thrombi identified by anatomopathology at the time of inferior vena cava filters (IVCF) retrievable was associated with the occurrence of a venous thromboembolism event within 3 months following removal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Retrievable Inferior Vena Cava Filters (IVCF) | Analysis anatomopathology of Retrievable Inferior Vena Cava Filters (IVCF) (ALN CF model). |
| OTHER | Demographics data collection | Demographics data : age, gender, thromboembolic risk factors, Retrievable Inferior Vena Cava Filters (IVCF) (indication, dates of insertion and removal), and anticoagulant management during the period with filter. |
Timeline
- Start date
- 2015-01-15
- Primary completion
- 2015-04-30
- Completion
- 2015-04-30
- First posted
- 2021-03-05
- Last updated
- 2021-03-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04785313. Inclusion in this directory is not an endorsement.